Dakota T. Carter
Dakota T. Carter has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ambika Poudel
DōTERRA International, Pleasant Grove, UT 84062, USA
2 shared publications - Cécile Bascoul
DōTERRA International, Pleasant Grove, UT 84062, USA
2 shared publications - Joseph T. Dawson
DōTERRA International, Pleasant Grove, UT 84062, USA
2 shared publications - Prabodh Satyal
Aromatic Plant Research Center, 230 N 1200 E, Suite 100, Lehi, UT 84043, USA
2 shared publications - Sara A. Shah
DōTERRA International, Pleasant Grove, UT 84062, USA
2 shared publications - Tim Lindberg
SenzaGen AB, 22381 Lund, Sweden
2 shared publications
Latest Publications
- Open Access
Comparative Analysis of Test Methods for Predicting Dermal Sensitization Potency in Essential Oils: A Component-Based Prediction Model, GARDskin Dose–Response Assay, and Local Lymph Node Assay
The dose–response adaptation of the genomic allergen rapid detection for skin sensitizers (GARDskin DR) assay is a non-animal method for predicting sensitization potency. This proof-of-concept comparative analysis evaluates outputs from a component-based prediction model (CP), GARDskin DR, and historical local lymph node assays (LLNA), exploring the applicability of CP and GARDskin DR for evaluating the no-expected-sensitization induction level (NESIL) potencies of essential oils. Eight well-studied essential oils were selected: cedarwood, cinnamon bark, clove bud, geranium, lavender, lemongrass, spearmint, and tea tree oils. Each underwent GARDskin DR as well as GC–MS, from which CP model outputs were derived. GARDskin DR, CP, and LLNA outputs were compared graphically and using preliminary descriptive statistics. Results show overall statistical concordance in material ranking between methods (Kendall’s W = 0.857, p = 0.017). Bland–Altman log-transformed bias and limits of agreement show numerically higher NESILCP compared to corresponding NESILGARD and NESILLLNA, but sensitivity analysis shows this finding is statistically sensitive to geranium oil. Spearman’s rank correlations were significant between NESILCP vs. NESILGARD and NESILLLNA but not between NESILGARD vs. NESILLLNA despite numerical similarity. Given the small sample, no statistical findings from this study are generalizable and should be interpreted descriptively. However, the NESIL results provide preliminary evidence supporting further evaluation of GARDskin DR and CP for dermal sensitization potency testing of essential oils.
Open AccessComparative Analysis of Test Methods for Predicting Dermal Sensitization Potency in Essential Oils: A Component-Based Prediction Model, GARDskin Dose–Response Assay, and Local Lymph Node Assay
The dose–response adaptation of the genomic allergen rapid detection for skin sensitizers (GARDskin DR) assay is a non-animal method for predicting sensitization potency. This proof-of-concept comparative analysis evaluates outputs from a component-based prediction model (CP), GARDskin DR, and historical local lymph node assays (LLNA), exploring the applicability of CP and GARDskin DR for evaluating the no-expected-sensitization induction level (NESIL) potencies of essential oils. Eight well-studied essential oils were selected: cedarwood, cinnamon bark, clove bud, geranium, lavender, lemongrass, spearmint, and tea tree oils. Each underwent GARDskin DR as well as GC–MS, from which CP model outputs were derived. GARDskin DR, CP, and LLNA outputs were compared graphically and using preliminary descriptive statistics. Results show overall statistical concordance in material ranking between methods (Kendall’s W = 0.857, p = 0.017). Bland–Altman log-transformed bias and limits of agreement show numerically higher NESILCP compared to corresponding NESILGARD and NESILLLNA, but sensitivity analysis shows this finding is statistically sensitive to geranium oil. Spearman’s rank correlations were significant between NESILCP vs. NESILGARD and NESILLLNA but not between NESILGARD vs. NESILLLNA despite numerical similarity. Given the small sample, no statistical findings from this study are generalizable and should be interpreted descriptively. However, the NESIL results provide preliminary evidence supporting further evaluation of GARDskin DR and CP for dermal sensitization potency testing of essential oils.
- Open Access
- 7 July 2026
- Published by MDPI AG in Preprints.org
Comparative Analysis of Test Methods for Predicting Dermal Sensitization Potency in Essential Oils: A Component-Based Prediction Model, GARDskin Dose-Response Assay, and Local Lymph Node Assay
The GARDskin DR assay is a non-animal method that predicts dermal sensitization potency of discrete compounds. This comparative analysis evaluates outputs from a component-based prediction model (CP), GARDskin DR, and historical local lymph node assays (LLNA) exploring the applicability of CP and GARDskin DR for evaluating the sensitization potencies of essential oils. Eight well-studied essential oils were selected including cedarwood, cinnamon bark, clove bud, geranium, lavender, lemongrass, spearmint, and tea tree oils. Each underwent GC-MS and GARDskin DR analysis. CP model outputs, GARDskin DR and reference LLNA data were compared using standard statistical methods. Spearman’s test shows significant correlation between NESILCP vs. NESILGARD (0.881, p = 0.007) and NESILLLNA (0.929, p = 0.007) but not between NESILGARD vs. NESILLLNA (0.607, p = 0.17). Friedman’s test detected a significant difference among methods (χ²(2) = 7.71, p = 0.021), with post hoc tests showing relatively greater NESILCP values. Kendall’s W shows overall strong statistical concordance between methods (0.857, p = 0.017). NESILGARD and NESILCP generally align with NESILLLNA for the essential oils tested, although the CP method yields greater values. With the limited number of materials tested, results should be interpreted descriptively but show promise for GARDskin DR and CP for evaluating dermal sensitization potency of essential oils.
- 7 July 2026
- Published by MDPI AG in Preprints.org
Open AccessComparative Analysis of Test Methods for Predicting Dermal Sensitization Potency in Essential Oils: A Component-Based Prediction Model, GARDskin Dose-Response Assay, and Local Lymph Node Assay
The GARDskin DR assay is a non-animal method that predicts dermal sensitization potency of discrete compounds. This comparative analysis evaluates outputs from a component-based prediction model (CP), GARDskin DR, and historical local lymph node assays (LLNA) exploring the applicability of CP and GARDskin DR for evaluating the sensitization potencies of essential oils. Eight well-studied essential oils were selected including cedarwood, cinnamon bark, clove bud, geranium, lavender, lemongrass, spearmint, and tea tree oils. Each underwent GC-MS and GARDskin DR analysis. CP model outputs, GARDskin DR and reference LLNA data were compared using standard statistical methods. Spearman’s test shows significant correlation between NESILCP vs. NESILGARD (0.881, p = 0.007) and NESILLLNA (0.929, p = 0.007) but not between NESILGARD vs. NESILLLNA (0.607, p = 0.17). Friedman’s test detected a significant difference among methods (χ²(2) = 7.71, p = 0.021), with post hoc tests showing relatively greater NESILCP values. Kendall’s W shows overall strong statistical concordance between methods (0.857, p = 0.017). NESILGARD and NESILCP generally align with NESILLLNA for the essential oils tested, although the CP method yields greater values. With the limited number of materials tested, results should be interpreted descriptively but show promise for GARDskin DR and CP for evaluating dermal sensitization potency of essential oils.